27/09/2024 PRAC September 2024 – Recommendation for metamizole and to minimise the risk associated with medroxyprogesterone acetate
19/09/2024 Limited availability of Zypadhera powder and solvent for suspension with prolonged release used for injections: recommendations update
04/09/2024 Limited availability of medicinal product based on peginterferon alfa-2a, solution for injection: recommendations for physicians (-specialists) and (hospital) pharmacists.